Vanta Holdings Unveils Capital Markets Plan to Bolster Financial Stability

Vanta Holdings Inc., a consumer health sciences firm, has announced revisions to its proposed non-brokered private placement, initially communicated in January 2026. The company plans to issue up to 1,000,000 units at $1.00 each, potentially raising $1 million. Each unit comprises one common share and one warrant, which allows the purchase of an additional share at $1.25 within 24 months. The closing is expected around April 2, 2026, following compliance with Canadian Securities Exchange policies.

The proceeds will fund business initiatives, payables, corporate awareness, and general working capital. Additionally, Vanta aims to address a $500,000 debt through issuing 250,000 common shares at a deemed price of $2.00 each. This debt settlement should conclude by April 2, 2026, contingent on regulatory approval.

Insider participation may trigger related party transaction rules, yet exemptions are anticipated due to the transaction's limited size relative to Vanta’s market capitalization. This release is informational and not a solicitation in jurisdictions where it'd be unlawful. No U.S. sales will occur without proper registration or exemption.